Gender and the Sex Hormone Estradiol Affect Multiple Sclerosis Risk Gene Expression in Epstein-Barr Virus-Infected B...

Area of Science:

• Neuroimmunology
• Virology
• Genetics

Background:

• Multiple Sclerosis (MS) is an immune-mediated central nervous system disease with unknown etiology.
• B cells are implicated in MS pathogenesis and are hosts for Epstein-Barr Virus (EBV), a suspected environmental trigger.
• Females exhibit a 2-3 fold higher incidence of MS compared to males.

Purpose of the Study:

• To investigate if genetic loci associated with MS risk mediate the observed gender imbalance in MS incidence.
• To explore potential estrogen-mediated mechanisms underlying sex-specific differences in MS susceptibility.

Main Methods:

• Analysis of a large public dataset to identify gender-specific associations between MS risk SNPs, EBV traits, and gene expression.
• In vitro culture of EBV-infected B cells (lymphoblastoid cell lines) with and without estradiol to assess sex-dependent effects.
• Measurement of gene expression, cell proliferation, EBV DNA copy number, and EBNA2 expression.

Main Results:

• Identified gender-specific associations between MS risk variants and EBV-related gene expression, with some genes showing differential correlation with Estrogen Receptor 2.
• Estradiol treatment of EBV-infected B cells demonstrated sex-dependent alterations in MS risk gene expression, EBV load, and EBNA2 levels.
• Evidence suggests estrogen plays a role in sex-specific differences in MS risk gene regulation and EBV biology.

Conclusions:

• Estrogen-mediated, gender-specific differences in MS risk gene expression and EBV functions contribute to differential host responses.
• These findings offer insights into the higher susceptibility of females to MS and the complex interplay between genetics, EBV, and sex hormones.
• The study identifies potential therapeutic targets for mitigating MS risk in a sex-specific manner.